Antibacterial effects of volatiles produced by Bacillus strain D13 against Xanthomonas oryzae pv. oryzae

Mol Plant Pathol. 2018 Jan;19(1):49-58. doi: 10.1111/mpp.12494. Epub 2016 Nov 23.

Abstract

Recent investigations have demonstrated that bacteria employ the volatile compounds they produce during interactions with other organisms, such as plants, fungi, nematodes and bacteria. However, studies focused on the antibacterial activity of plant growth-promoting rhizobacteria (PGPR) volatiles against bacterial phytopathogens are still rare. In this study, Bacillus strain D13, which is antagonistic to Xanthomonas oryzae pv. oryzae (Xoo), was isolated and screened. Volatile compounds emitted from strain D13 reduced the colony diameter and cell motility of Xoo cultured in divided Petri plates. Transmission electron micrograph analysis showed concentration in cytoplasm and altered surface morphology in the majority of Xanthomonas cells after co-cultivation with strain D13. Transcriptional expression of virulence-associated genes in Xoo was repressed. Based on gas chromatography/mass spectrometry (GC/MS) analysis, 12 volatile compounds specifically produced by strain D13 were identified. Among them, decyl alcohol and 3,5,5-trimethylhexanol inhibited the growth of Xoo at minimum inhibitory amounts of 0.48 and 2.4 mg, respectively. Furthermore, transcriptional expression of virulence-associated genes was also repressed by decyl alcohol and 3,5,5-trimethylhexanol. These results are useful for a better understanding of the biocontrol mechanisms of Bacillus.

Keywords: Bacillus; antibacterial activity; volatile compounds, Xanthomonas oryzae pv. oryzae.

MeSH terms

  • Anti-Bacterial Agents / pharmacology*
  • Bacillus / metabolism*
  • Coculture Techniques
  • Gene Expression Regulation, Bacterial / drug effects
  • Microbial Sensitivity Tests
  • Movement
  • Phylogeny
  • Transcription, Genetic / drug effects
  • Virulence / drug effects
  • Virulence / genetics
  • Volatile Organic Compounds / pharmacology*
  • Xanthomonas / drug effects*
  • Xanthomonas / pathogenicity
  • Xanthomonas / ultrastructure

Substances

  • Anti-Bacterial Agents
  • Volatile Organic Compounds